Evidence map›Paper›PMID 31801397›Full record

ArticleInternational journal of surgical pathology2020

Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.

Nicholas Olson, Rodrigo Gularte-Mérida, Pier Selenica, Arnaud Da Cruz Paula, Barbara Alemar, Britta Weigelt, Joel Lefferts, Konstantinos Linos

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of surgical pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nicholas OlsonDartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, NH, USA.ORCID https://orcid.org/0000-0002-6745-3587
Rodrigo Gularte-MéridaMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Pier SelenicaMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Arnaud Da Cruz PaulaMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Barbara AlemarMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Britta WeigeltMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Joel LeffertsDartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, NH, USA.
Konstantinos LinosDartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, NH, USA.
Memorial Sloan Kettering Cancer Center · USDartmouth–Hitchcock Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA023108
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorBiopsyCell DedifferentiationChemoradiotherapy, AdjuvantDiagnosis, DifferentialExome SequencingFatal OutcomeFemaleGene AmplificationHumansIn Situ Hybridization, FluorescenceLiposarcomaProto-Oncogene Proteins c-mdm2Retroperitoneal NeoplasmsRetroperitoneal SpaceRhabdomyosarcoma, EmbryonalBiomarkers, TumorMDM2 protein, humanProto-Oncogene Proteins c-mdm2amplificationdedifferentiationliposarcomaMDM2rhabdomyosarcoma

Identifiers

PMID31801397
PMCPMC8302235
OpenAlexW2994568183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.